SECRETION - 372 Annonces
401120 MédicalSignalez un abus
Thursday 31 July 2025
Quantité : 20mg*10via - Prix : USD 300
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MédicalSignalez un abus
Thursday 31 July 2025
Quantité : 15mg*10via - Prix : USD 230
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MédicalSignalez un abus
Thursday 31 July 2025
Quantité : 10mg*10via - Prix : USD 180
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MédicalSignalez un abus
Thursday 31 July 2025
Quantité : 5mg*10vial - Prix : USD 130
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MédicalSignalez un abus
Tuesday 29 July 2025
Quantité : 60mg*10via - Prix : USD 650
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
401120 MédicalSignalez un abus
Tuesday 29 July 2025
Quantité : 50mg*10via - Prix : USD 550
Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +17 3 16 83 50 63
